Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marschang

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Archives of Allergy and Immunology|January 1, 1994
HIV and complement: role of the complement system in HIV infectionP Marschang, C F Ebenbichler, M P Dierich
European Journal of Immunology|January 1, 1995
Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complementP Marschang, J Sodroski, R Würzner, et al.
Archivum Immunologiae Et Therapiae Experimentalis|September 27, 2015
Impact of Whole Body Cryotherapy at -110 °C on Subjects with Arterial HypertensionM Missmann, M Himsl, E Mur, et al.
European Journal of Immunology|April 1, 1994
A novel, complement factor H-related regulatory protein expressed on the surface of human B cell linesA Erdei, N Julen, P Marschang, et al.
Journal of the American College of Cardiology|November 3, 2001
Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking menH Gaenzer, G Neumayr, P Marschang, et al.
Journal of Internal Medicine|August 3, 2006
Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatinP Marschang, A Sandhofer, A Ritsch, et al.
The Journal of Experimental Medicine|December 1, 1991
Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41C F Ebenbichler, N M Thielens, R Vornhagen, et al.
Immunology Today|September 1, 1993
HIV and human complement: mechanisms of interaction and biological implicationM P Dierich, C F Ebenbichler, P Marschang, et al.
Immunology Letters|November 1, 1989
Anti-viral antibodies in HIV (HTLV-III) infection possess auto-antibody activity against a CH1 domain determinant in human IgG: possible immunological consequencesB Sölder, P Marschang, H Wachter, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
Complement activation by HIV-1-infected cells: the role of transmembrane glycoprotein gp41P Marschang, U Krüger, C Ochsenbauer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Archives of Allergy and Immunology|January 1, 1994
HIV and complement: role of the complement system in HIV infectionP Marschang, C F Ebenbichler, M P Dierich
European Journal of Immunology|January 1, 1995
Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complementP Marschang, J Sodroski, R Würzner, et al.
Archivum Immunologiae Et Therapiae Experimentalis|September 27, 2015
Impact of Whole Body Cryotherapy at -110 °C on Subjects with Arterial HypertensionM Missmann, M Himsl, E Mur, et al.
European Journal of Immunology|April 1, 1994
A novel, complement factor H-related regulatory protein expressed on the surface of human B cell linesA Erdei, N Julen, P Marschang, et al.
Journal of the American College of Cardiology|November 3, 2001
Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking menH Gaenzer, G Neumayr, P Marschang, et al.
Journal of Internal Medicine|August 3, 2006
Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatinP Marschang, A Sandhofer, A Ritsch, et al.
The Journal of Experimental Medicine|December 1, 1991
Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41C F Ebenbichler, N M Thielens, R Vornhagen, et al.
Immunology Today|September 1, 1993
HIV and human complement: mechanisms of interaction and biological implicationM P Dierich, C F Ebenbichler, P Marschang, et al.
Immunology Letters|November 1, 1989
Anti-viral antibodies in HIV (HTLV-III) infection possess auto-antibody activity against a CH1 domain determinant in human IgG: possible immunological consequencesB Sölder, P Marschang, H Wachter, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
Complement activation by HIV-1-infected cells: the role of transmembrane glycoprotein gp41P Marschang, U Krüger, C Ochsenbauer, et al.
Pageof 2